A walkthrough of Revvity’s experience, key factors, and decisions that led to the adoption of AI‑native development and the Tiny Teams concept. The session will discuss the approach to spec‑driven development to drive innovation across the organization at scale, as well as showcase a tool developed to ensure that the speed of AI‑generated artifacts is matched with the processes required to meet quality, compliance, and testing standards in the life sciences industry.